4,4'-二甲基阿米雷司
外觀
臨床資料 | |
---|---|
其他名稱 | 4,4'-DMAR |
ATC碼 |
|
法律規範狀態 | |
法律規範 | |
識別資訊 | |
| |
CAS號 | 1445569-01-6 |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C11H14N2O |
摩爾質量 | 190.25 g·mol−1 |
3D模型(JSmol) | |
| |
|
4,4'-二甲基阿米雷司(英語:4,4'-Dimethylaminorex,縮寫4,4'-DMAR),分子式C11H14N2O,是一種興奮劑和狡詐家藥物,與阿米雷司、4-甲基阿米雷司一樣帶有噁唑啉基團[3],2012年12月首次在荷蘭出現[4]。
參考文獻
[編輯]- ^ 2021 - Placement of 4,4'-DMAR in Schedule I. www.deadiversion.usdoj.gov. [2021-10-14].
- ^ Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-07-24 (2023-07-25) [2023-08-27]. (原始內容存檔於2023-08-27) (巴西葡萄牙語).
- ^ Brandt SD, Baumann MH, Partilla JS, Kavanagh PV, Power JD, Talbot B, et al. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni'). Drug Testing and Analysis. 2014, 6 (7–8): 684–95. PMC 4128571 . PMID 24841869. doi:10.1002/dta.1668.
- ^ EMCDDA 2012 Annual report on the state of the drugs problem in Europe (PDF). [2014-04-21]. (原始內容存檔 (PDF)於2014-04-23).